Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Integrated Immune Signature Analyses Identifies Evolution of Distinct Immunoregulatory Cell Populations Which Control Alloreactivity after Allogeneic HSCT

James Aries, Sarah Charrot, Jennifer Ball, Matthew Mee, Symeon Theocharidis, Sofie Van Gassen, Sameena Iqbal, John G. Gribben, MD DSc, Jeff Davies, MBBS, PhD

Blood (2019) 134 (Supplement_1): 595.

https://doi.org/10.1182/blood-2019-124875

Published: 2019

Journal Articles

Primary Human NK Cell Gene-Editing Reveals a Critical Role for NKG2A in Cytokine-Induced Memory-like NK Cell Responses

Melissa M Berrien-Elliott, PhD, Wong Pamela, B.S., Carly Neal, B.S., Julia A Wagner, PhD, Michelle Becker-Hapak, BS, Tim Schappe, BS, Matthew L. Cooper, PhD, Emily M Mace, PhD, Todd A Fehniger, MD PhD

Blood (2019) 134 (Supplement_1): 3237.

https://doi.org/10.1182/blood-2019-129162

Published: 2019

Journal Articles

Deep Phenotypic Analysis Reveals a Monocyte Subpopulation Predictive of Relapse/Refractory Diffuse Large B-Cell Lymphoma

Edward Truelove, MBBS, BSc, MRCP, FRCPath, Frances Seymour, MRCP, BSc, MBBS, Janet Matthews, John G. Gribben

Blood (2018) 132 (Supplement 1): 2863.

https://doi.org/10.1182/blood-2018-99-119756

Published: 2018

Journal Articles

Characterization of the Immune Impact of Daratumumab By Mass Cytometry in Multiple Myeloma

Sarah K Johnson, PhD, Stephen Burke, PhD, Matthew Henry, M.S., Amy Greenway, Katie Stone, BS, Brian A Walker, PhD, Frits van Rhee, MD PhD, Gareth Morgan, MD

Blood (2018) 132 (Supplement 1): 4466.

https://doi.org/10.1182/blood-2018-99-119241

Published: 2018

Journal Articles

Deep Immunoprofiling of the Bone Marrow Microenvironmental Changes Underlying the Multistep Progression of Multiple Myeloma

Mary H Young, PhD, Sam A Danziger, Alison Fitch, Frank Schmitz, MD PhD, Jake Gockley, PhD, Mark McConnell, PhD, David Reiss, PhD, Wilbert B. Copeland, PhD, Sarah K Johnson, PhD, Katie Newhall, PhD, Robert Hershberg, MD PhD, Teri Foy, PhD, Alexander Ratushny, PhD, Brian A Walker, PhD, Andrew Dervan, Gareth Morgan, MD

Blood (2018) 132 (Supplement 1): 243.

https://doi.org/10.1182/blood-2018-99-113042

Published: 2018

Journal Articles

Characterising the Immunological Microenvironment in Newly Diagnosed Multiple Myeloma Bone Marrow By Time of Flight Cytometry Reveals Abnormalities in Antigen Presenting and Effector Lymphocyte Populations with Prognostic Significance

Frances Seymour, MRCP, BSc, MBBS, Jamie Cavenagh, MD PhD, John G. Gribben

Blood (2018) 132 (Supplement 1): 58.

https://doi.org/10.1182/blood-2018-99-114102

Published: 2018

Journal Articles

Altered Peripheral Immune Phenotypes in Mantle Cell Lymphoma Survivors

Tanaya Shree, MD PhD, Sangeeta Kowli, PhD, Holden T. Maecker, PhD, Ronald Levy, MD

Blood (2017) 130 (Supplement 1): 2759.

https://doi.org/10.1182/blood.V130.Suppl_1.2759.2759

Published: 2017

Journal Articles

NKG2A Represents an Important Immune Checkpoint for Human Cytokine-Induced Memory-like NK Cells in Patients with AML

Melissa Berrien-Elliott, PhD, Rizwan Romee, MD, Julia Alexandra Wagner, BS, Michelle Becker-Hapak, BS, Carly Neal, Tim Schappe, BS, Matthew McCullen, BS, Megan Cooper, MD PhD, Todd A. Fehniger, MDPhD

Blood (2017) 130 (Supplement 1): 167.

https://doi.org/10.1182/blood.V130.Suppl_1.167.167

Published: 2017

Journal Articles

Wouldn't have happened to a Limey

Neil Abramson

Blood (2012) 119 (8): 1800.

https://doi.org/10.1182/blood-2011-05-353524

Published: 2012

Journal Articles

Galectin-3 Is the Molecular Target for Overcoming Multidrug Resistance Due to the Cell Protection by Bone Marrow Leukemia Microenvironment in Chronic Myeloid Leukemia,

Mio Yamamoto, Junya Kuroda, MD, PhD, Tsutomu Kobayashi, MD, PhD, Nana Sasaki, MD, Hisao Nagoshi, Yuji Shimura, Miki Kiyota, Ryuko Nakayama, Shigeo Horiike, MD, PhD, Eishi Ashihara, MD, PhD, Kenichi Akaji, PhD, Masafumi Taniwaki, MD, PhD

Blood (2011) 118 (21): 3746.

https://doi.org/10.1182/blood.V118.21.3746.3746

Published: 2011

Journal Articles

GCS-100 Targets Apoptosis and Cell Cycle Regulation in Myeloma Cells.

Matthew Streetly, BMBS, MRCP, MRCPath, Lenushka Maharaj, Simon P Joel, Finbarr E Cotter, FRCP, FRCPath, PhD

Blood (2009) 114 (22): 4923.

https://doi.org/10.1182/blood.V114.22.4923.4923

Published: 2009

Journal Articles

Mcl-1, Bcl-x L and Cell Cycle Inhibition by GCS-100: A Novel Therapy for Myeloma.

Matthew Streetly, Bo Su, Bradley Carver, Stephen A. Schey, Finbarr E. Cotter

Blood (2006) 108 (11): 3471.

https://doi.org/10.1182/blood.V108.11.3471.3471

Published: 2006

Journal Articles

Expression and Modulation of Carbohydrate-Binding Protein Galectin-3 in Multiple Myeloma Cells by Combined Treatment with GCS-100 and Dexamethasone.

Dharminder Chauhan, PhD, Yan Chang, Ph.D, Deli He, M.S, Teru Hideshima, MD, Ph.D, Klaus Podar, M.D, Florence Tao, Ph.D, Paola Neri, M.D, Robert Schlossman, M.D, Joanne Schindler, M.D, Bradley Carver, M.D, Paul Richardson, M.D, Kenneth C. Anderson, M.D

Blood (2005) 106 (11): 4447.

https://doi.org/10.1182/blood.V106.11.4447.4447

Published: 2005

Journal Articles

Tangeretin Induces Caspase Dependent Apoptosis and G2/M Arrest in the Erythroleukemia Cell Line K562 In Vitro.

Lust Sofie, Vanhoecke Barbara, Bracke Marc, MD, PhD, Offner Fritz, MD, PhD

Blood (2005) 106 (11): 4435.

https://doi.org/10.1182/blood.V106.11.4435.4435

Published: 2005

Journal Articles

Tangeretin Synergizes with Imatinib in Inhibiting Growth of Bcr-Abl Positive K562 Erythroleukemia Cells in an Erk-Dependent Way.

Sofie Lust, Barbara Vanhoecke, Marc Bracke, MD PhD, Fritz Offner, MD PhD

Blood (2004) 104 (11): 2093.

https://doi.org/10.1182/blood.V104.11.2093.2093

Published: 2004

Journal Articles

GCS-100, a Galectin 3 Antagonist, Is a Novel Caspase-9 Apoptosis Activating Agent for the Treatment of Indolent B-Cell Malignancies.

Finbarr E. Cotter, MD PhD, Bo Su, MD, Margherita Corbo, BSc, Y. Chang, Joanne Schindler, Brad Carver, Christopher D. Fegan, MD, Adrian C. Newland, MD, Rebecca L. Auer, MD PhD

Blood (2004) 104 (11): 3286.

https://doi.org/10.1182/blood.V104.11.3286.3286

Published: 2004

NARROW

Integrated Immune Signature Analyses Identifies Evolution of Distinct Immunoregulatory Cell Populations Which Control Alloreactivity after Allogeneic HSCT

Primary Human NK Cell Gene-Editing Reveals a Critical Role for NKG2A in Cytokine-Induced Memory-like NK Cell Responses

Deep Phenotypic Analysis Reveals a Monocyte Subpopulation Predictive of Relapse/Refractory Diffuse Large B-Cell Lymphoma

Characterization of the Immune Impact of Daratumumab By Mass Cytometry in Multiple Myeloma

Deep Immunoprofiling of the Bone Marrow Microenvironmental Changes Underlying the Multistep Progression of Multiple Myeloma

Characterising the Immunological Microenvironment in Newly Diagnosed Multiple Myeloma Bone Marrow By Time of Flight Cytometry Reveals Abnormalities in Antigen Presenting and Effector Lymphocyte Populations with Prognostic Significance

Altered Peripheral Immune Phenotypes in Mantle Cell Lymphoma Survivors

NKG2A Represents an Important Immune Checkpoint for Human Cytokine-Induced Memory-like NK Cells in Patients with AML

Wouldn't have happened to a Limey

Galectin-3 Is the Molecular Target for Overcoming Multidrug Resistance Due to the Cell Protection by Bone Marrow Leukemia Microenvironment in Chronic Myeloid Leukemia,

GCS-100 Targets Apoptosis and Cell Cycle Regulation in Myeloma Cells.

Mcl-1, Bcl-x L and Cell Cycle Inhibition by GCS-100: A Novel Therapy for Myeloma.

Expression and Modulation of Carbohydrate-Binding Protein Galectin-3 in Multiple Myeloma Cells by Combined Treatment with GCS-100 and Dexamethasone.

Tangeretin Induces Caspase Dependent Apoptosis and G2/M Arrest in the Erythroleukemia Cell Line K562 In Vitro.

Tangeretin Synergizes with Imatinib in Inhibiting Growth of Bcr-Abl Positive K562 Erythroleukemia Cells in an Erk-Dependent Way.

GCS-100, a Galectin 3 Antagonist, Is a Novel Caspase-9 Apoptosis Activating Agent for the Treatment of Indolent B-Cell Malignancies.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only